{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:36:27Z","timestamp":1773286587911,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.067","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T14:08:39Z","timestamp":1123682919000},"page":"133-143","source":"Crossref","is-referenced-by-count":48,"title":["Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys"],"prefix":"10.1016","volume":"24","author":[{"given":"Alexander A.","family":"Rumyantsev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Chanock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander G.","family":"Pletnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.067_bib1","series-title":"Fields virology","first-page":"196","author":"Monath","year":"1996"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.067_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/0022-1317-74-2-287","article-title":"Nucleotide and deduced amino acid sequence of the envelope glycoprotein of Omsk hemorrhagic fever virus; comparison with other flaviviruses","volume":"74","author":"Gritsun","year":"1993","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/viro.1993.1247","article-title":"Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses","volume":"194","author":"Mandl","year":"1993","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/0022-1317-75-1-227","article-title":"Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex","volume":"75","author":"Venugopal","year":"1994","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib5","first-page":"89","article-title":"Vaccination of human volunteers against Russian spring\u2013summer (RSS) virus complex with attenuated Langat E5 virus","volume":"42","author":"Price","year":"1970","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.1973.22.100","article-title":"Immunization of mice against Russian spring\u2013summer virus complex and monkeys against Powassan virus with attenuated Langat E5 virus","volume":"22","author":"Price","year":"1973","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2005.07.067_bib7","series-title":"Vaccines.","first-page":"1039","article-title":"Tick-borne encephalitis virus vaccine","author":"Barrett","year":"2004"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(90)90172-I","article-title":"A new vaccine against tick-borne encephalitis: initial trial in man including a dose\u2013response study","volume":"8","author":"Bock","year":"1990","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2005.07.067_bib9","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0264-410X(96)00081-3","article-title":"Tick-borne encephalitis: development of a paediatric vaccine","volume":"14","author":"Girgsdies","year":"1996","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2005.07.067_bib10","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2005.07.067_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0264-410X(02)00592-3","article-title":"Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2005.07.067_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0020-7519(03)00063-8","article-title":"Traditional and novel approaches to flavivirus vaccines","volume":"33","author":"Pugachev","year":"2003","journal-title":"Int J Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.07.067_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2005.07.067_bib14","series-title":"Tick-borne encephalitis and its vaccine prophylaxis","first-page":"190","article-title":"Live vaccines against tick-borne encephalitis","author":"Smorodincev","year":"1986"},{"key":"10.1016\/j.vaccine.2005.07.067_bib15","series-title":"Tick-borne encephalitis","first-page":"49","article-title":"Study of the distant consequences of immunizing people with a live vaccine against tick-borne encephalitis","author":"Shapoval","year":"1989"},{"issue":"21","key":"10.1016\/j.vaccine.2005.07.067_bib16","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.067_bib17","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1128\/JVI.67.8.4956-4963.1993","article-title":"Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice","volume":"67","author":"Pletnev","year":"1993","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.067_bib18","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.95.4.1746","article-title":"Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4","volume":"95","author":"Pletnev","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/viro.2000.0426","article-title":"Bray M.Chimeric Langat\/dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus","volume":"274","author":"Pletnev","year":"2000","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.vaccine.2005.07.067_bib20","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1128\/JVI.75.17.8259-8267.2001","article-title":"Tick-borne Langat\/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes","volume":"75","author":"Pletnev","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.067_bib21","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/JVI.70.6.4162-4166.1996","article-title":"Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge","volume":"70","author":"Bray","year":"1996","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.07.067_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(01)00273-8","article-title":"Construction, characterization, and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus","volume":"79","author":"Caufour","year":"2001","journal-title":"Virus Res"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.067_bib23","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2005.07.067_bib24","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2005.07.067_bib25","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1128\/JVI.74.17.8094-8101.2000","article-title":"Chimeric yellow fever\/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response","volume":"74","author":"van der Most","year":"2000","journal-title":"J Virol"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2005.07.067_bib26","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/S0264-410X(03)00488-2","article-title":"Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys","volume":"21","author":"Whitehead","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.067_bib27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2005.07.067_bib28","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1128\/JVI.78.14.7418-7426.2004","article-title":"Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice","volume":"78","author":"Charlier","year":"2004","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2005.07.067_bib29","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.07.067_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb02680.x","article-title":"Prospects for development of a vaccine against the West Nile virus","volume":"951","author":"Monath","year":"2001","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.067_bib31","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecular engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.067_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in the 3\u2032 untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.067_bib35","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.70.6.3930-3937.1996","article-title":"Dengue type 4 virus mutants containing deletion in the 3\u2032 noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys","volume":"70","author":"Men","year":"1996","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.067_bib36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/JVI.77.2.1653-1657.2003","article-title":"A live attenuated dengue virus type 1 vaccine candidate with a 30 nucleotide deletion in the 3\u2032 untranslated region is highly attenuated and immunogenic in monkeys","volume":"77","author":"Whitehead","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/viro.2000.0220","article-title":"Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence","volume":"269","author":"Campbell","year":"2000","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.067_bib38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/viro.2001.0846","article-title":"Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3\u2032 deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice","volume":"282","author":"Pletnev","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2005.07.067_bib39","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"20","key":"10.1016\/j.vaccine.2005.07.067_bib40","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1128\/JVI.75.20.9731-9740.2001","article-title":"Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in Vero cells or human liver cells and attenuated in mice","volume":"75","author":"Blaney","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/viro.2002.1528","article-title":"Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells","volume":"300","author":"Blaney","year":"2002","journal-title":"Virology"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2005.07.067_bib42","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0264-410X(03)00487-0","article-title":"Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue type 2\/4 vaccine candidate in Vero cells","volume":"21","author":"Blaney","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.067_bib43","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/JVI.63.9.4034-4038.1989","article-title":"Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma","volume":"63","author":"Agol","year":"1989","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.067_bib44","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JVI.63.5.2357-2360.1989","article-title":"Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y","volume":"63","author":"La Monica","year":"1989","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.067_bib45","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/oxfordjournals.aje.a120665","article-title":"Experimental infection of monkeys with Langat virus. I","volume":"84","author":"Nathanson","year":"1966","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.07.067_bib46","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/JVI.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.067_bib47","first-page":"327","article-title":"Infection and immunity patterns in monkeys injected with viruses of Russian Spring\u2013Summer and Japanese encephalitis","volume":"62","author":"Morris","year":"1955","journal-title":"Am J Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.067_bib48","first-page":"425","article-title":"Experience in the study of a live vaccine made from the TP21 strain of Malayan Langat virus","volume":"39","author":"Il\u2019enko","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"21","key":"10.1016\/j.vaccine.2005.07.067_bib49","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.79.9.5516-5528.2005","article-title":"Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys","volume":"79","author":"Blaney","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.067_bib50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0042-6822(90)90073-Z","article-title":"Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus","volume":"174","author":"Pletnev","year":"1990","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T20:26:21Z","timestamp":1586377581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007449"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}